Inattention News and Research

RSS

High dopamine transporter levels not linked to attention-deficit hyperactivity disorder

Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease.

2 Dec 2006

Almost half of kids with ADHD are not being treated

In contrast to claims that children are being overmedicated for attention-deficit/hyperactivity disorder (ADHD), a team of researchers at Washington University School of Medicine in St. Louis has found that a high percentage of kids with ADHD are not receiving treatment.

4 Aug 2006

Midbrain, striatal and amygdalar dopaminergic dysfunction in ADHD

The brain's dopamine system, which has long been associated with reward learning and reward-related behavior, works differently in treated and untreated attention deficit hyperactivity disorder (ADHD) individuals.

7 Jun 2006

Link between children's sleep-related breathing problems and daytime behavior problems

Hyperactivity, attention deficit, sleepiness, and ADHD often improved - whether or not sleep studies showed sleep apnea before surgery.

4 Apr 2006

Poor children at greater risk for exposure to toxic pollutants

Poor and ethnic minority children in the United States have a significantly greater risk for exposure to toxic pollutants that can affect their cognitive development and other health indicators than higher income and non-minority peers, and current local, state and federal policies appear to be failing to address these inequities.

23 Mar 2006

Extreme personality poses risk of ADHD

Children with personalities marked by aggressiveness, mood swings, a sense of alienation and a need for excitement may be at greater risk for attention deficit hyperactivity disorder or conduct disorder, according to a new Florida State University study.

23 Mar 2006

Methylphenidate may be effective in treating autism

Methylphenidate, a medication used to treat attention-deficit hyperactivity disorder (ADHD), may be effective in treating hyperactivity symptoms in children with autism and related pervasive developmental disorders, researchers report in the November Archives of General Psychiatry.

26 Nov 2005

Methylphenidate shows promise for hyperactivity associated with autism

Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders, according to a study in the November issue of Archives of General Psychiatry.

7 Nov 2005

Anti-inflammatory function of Alzheimer's disease drugs revealed

The mechanism in anti-Alzheimer's disease drugs that inhibits the production of a destructive, inflammation-causing protein in the brain has been revealed by researchers at the Hebrew university of Jerusalem.

28 Jul 2005

Young children who snore more likely to be hyperactive later on

A new study has found that young children who snore could possibly be at greater risk of becoming hyperactive later, than those who sleep quietly.

4 Jul 2005

Children who snore are far more likely to suffer hyperactivity disorders

Several years ago, University of Michigan researchers published some of the strongest evidence yet that children who snore when they sleep are far more likely to have attention and hyperactivity problems than their non-snoring peers.

4 Jul 2005

Nearly half of non-ventilated patients in intensive care units experience delirium

A study published today in the open access journal Critical Care reveals for the first time that nearly half of non-ventilated patients in intensive care units (ICU) experience delirium, which is also an independent predictor of longer hospital stay. It was previously though that this was only an issue for mechanically-ventilated ICU patients.

31 May 2005

ADHD costs U.S. nearly $77 billion each year

U.S. household income losses due to attention-deficit/hyperactivity disorder (ADHD) total nearly $77 billion each year, according to a new analysis of the national large-scale survey, "Capturing America's Attention," presented today at the American Psychiatric Association (APA) annual meeting in Atlanta.

23 May 2005

Early home environment and television watching influence bullying behavior

Four-year-old children who receive emotional support and cognitive stimulation from their parents are significantly less likely to become bullies in grade school, but the more television four-year-olds watch the more likely they are to bully later, according to an article in the April issue of the Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

4 Apr 2005

Solving sleep problems helps epileptic children

Sleeping woes may explain why children with epilepsy are often so hyperactive, say researchers with the University of Florida's Evelyn F. and William L. McKnight Brain Institute.

30 Mar 2005

Computerized order entry systems can increase the risk of medication errors

A new study suggests that computerized order entry systems which are implemented in part to reduce prescribing errors can actually increase the risk of medication errors in certain situations, according to a study in the current issue of JAMA.

9 Mar 2005

Early ritalin may cause long-term effects on the brain

A new study conducted in rats by the National Institutes of Health (NIH) and McLean Hospital/Harvard Medical School suggests that the misdiagnosis of attention-deficit hyperactivity disorder (ADHD) combined with prescription drug use in children may lead to a higher risk of developing depressive symptoms in adulthood.

13 Dec 2004

Boys generally at greater risk of developing attention-deficit/hyperactivity disorder

Boys, in general, and children born to parents who have low education levels, in particular, are at an increased risk for developing attention-deficit/hyperactivity disorder (ADHD) compared to girls and children born to parents with high levels of education, according to a study of 5,701 children in Olmsted County, Minn.

14 Sep 2004

Attention deficit hyperactivity disorder costs the U.S. $77 billion each year

A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.

9 Sep 2004

FDA approval for chewable ADHD tablets

Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.

7 Sep 2004